Botulinum toxin type b
Myobloc, NeuroBloc (botulinum toxin type b) is an unknown pharmaceutical. Botulinum toxin type b was first approved as Myobloc on 2001-01-22. It is used to treat sialorrhea in the USA. It has been approved in Europe to treat torticollis.
|Common Name||Botulinum toxin type b|
|Drug Class||Fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)|